4-(4-(benzo[d][1,3]dioxol-5-ylmethyl)piperazin-1-yl)-5-phenyl-5H-pyrrolo[3,2-d]pyrimidine-7-carbonitrile

ID: ALA5291352

Max Phase: Preclinical

Molecular Formula: C25H22N6O2

Molecular Weight: 438.49

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  N#Cc1cn(-c2ccccc2)c2c(N3CCN(Cc4ccc5c(c4)OCO5)CC3)ncnc12

Standard InChI:  InChI=1S/C25H22N6O2/c26-13-19-15-31(20-4-2-1-3-5-20)24-23(19)27-16-28-25(24)30-10-8-29(9-11-30)14-18-6-7-21-22(12-18)33-17-32-21/h1-7,12,15-16H,8-11,14,17H2

Standard InChI Key:  BWQDVZLEAJDKCR-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 33 38  0  0  0  0  0  0  0  0999 V2000
    0.6520   -3.9668    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4074   -3.1789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1679   -2.4074    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6850   -1.7492    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2236   -1.0772    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5268   -0.3285    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0103    0.3185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2863    1.0684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0804    1.1983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5983    0.5783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3221   -0.1715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5466   -1.2897    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5808   -2.1042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3036   -2.4818    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9923   -2.0450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9582   -1.2306    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2354   -0.8530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2012   -0.0386    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8900    0.3981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8558    1.2124    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1330    1.5902    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0989    2.4045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3760    2.7822    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3419    3.5966    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3810    3.9742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0697    3.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8400    3.7499    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3013    3.0779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7843    2.4198    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0355    2.7231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3127    2.3453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4443    1.1533    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4784    0.3390    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  3  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
  6 11  1  0
  5 12  1  0
 12 13  2  0
  3 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 12 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 26 30  1  0
 29 30  1  0
 30 31  2  0
 23 31  1  0
 21 32  1  0
 32 33  1  0
 18 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5291352

    ---

Associated Targets(Human)

ABCC1 Tchem Multidrug resistance-associated protein 1 (2587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABCB1 Tchem P-glycoprotein 1 (14716 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABCG2 Tchem ATP-binding cassette sub-family G member 2 (4927 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 438.49Molecular Weight (Monoisotopic): 438.1804AlogP: 3.34#Rotatable Bonds: 4
Polar Surface Area: 79.44Molecular Species: NEUTRALHBA: 8HBD:
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.02CX LogP: 4.17CX LogD: 4.02
Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.48Np Likeness Score: -1.38

References

1. Stefan K, Schmitt SM, Wiese M..  (2017)  9-Deazapurines as Broad-Spectrum Inhibitors of the ABC Transport Proteins P-Glycoprotein, Multidrug Resistance-Associated Protein 1, and Breast Cancer Resistance Protein.,  60  (21): [PMID:29016119] [10.1021/acs.jmedchem.7b00788]
2. Jedlitschky, G G and 5 more authors.  1997-10-01  ATP-dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepatocyte canalicular isoform MRP2.  [PMID:9355767]
3. Wong, Iris L K ILK and 7 more authors.  2018-11-21  Discovery of Novel Flavonoid Dimers To Reverse Multidrug Resistance Protein 1 (MRP1, ABCC1) Mediated Drug Resistance in Cancers Using a High Throughput Platform with "Click Chemistry".  [PMID:30351934]
4. Zhu, Xuezhen and 8 more authors.  2019-09-26  Triazole Bridged Flavonoid Dimers as Potent, Nontoxic, and Highly Selective Breast Cancer Resistance Protein (BCRP/ABCG2) Inhibitors.  [PMID:31465686]

Source